<?xml version="1.0" encoding="UTF-8"?>
<p>Hydroxychloroquine, lopinavir/ritonavir, chloroquine, and darunavir/cobicistat are being used for patients with severe conditions. Interferon-beta B1 is extensively used for critical patients [
 <xref rid="B110-ijerph-17-05904" ref-type="bibr">110</xref>]. Another drug, oseltamivir, is being used in China by the medical personnel for suspected patients, but there is a lack of evidence on the specific activity of oseltamivir against COVID-19. A 54-year-old female patient from Wuhan city presented with fever for the past two days. Two tests were conducted, the first test was not positive, but the second test confirmed the disease. Meanwhile, this woman was treated with oseltamivir for three days, and her chest CT indicated reminiscent improvement in the density of GGO [
 <xref rid="B90-ijerph-17-05904" ref-type="bibr">90</xref>].
</p>
